LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)

 Full screen view
Filter results: >>>>
Cell Small Molecule Small Mol Concentration (uM) Time Point (hr) Total Cell Count Before Treatment Total Cell Count After Treatment Total Control Cell Count Relative Cell Count Normalized Growth Rate Inhibition Value Assay Plate Assay Well
MCF 10A-H2B-mCherry Dasatinib
0.031667
 65.70 84.90 336 8484 0.0396 0.2301
MN20160318_Q02
I11
MCF 10A-H2B-mCherry Dasatinib
0.031667
 65.70 84.90 6353 8484 0.7488 0.9148
MN20160318_Q02
I11
MCF 10A-H2B-mCherry Dasatinib
0.031667
 67.41 84.90 1060 8766 0.1209 0.4584
MN20160318_Q02
E06
MCF 10A-H2B-mCherry Dasatinib
0.031667
 67.41 84.90 5055 8766 0.5766 0.8420
MN20160318_Q02
E06
MCF 10A-H2B-mCherry Dasatinib
0.031667
 67.41 84.90 246 8766 0.0281 0.1724
MN20160318_Q02
I11
MCF 10A-H2B-mCherry Dasatinib
0.031667
 67.41 84.90 6328 8766 0.7219 0.9049
MN20160318_Q02
I11
MCF 10A-H2B-mCherry Dasatinib
0.031667
 69.11 84.90 931 8988 0.1036 0.4277
MN20160318_Q02
E06
MCF 10A-H2B-mCherry Dasatinib
0.031667
 69.11 84.90 5062 8988 0.5632 0.8364
MN20160318_Q02
E06
MCF 10A-H2B-mCherry Dasatinib
0.031667
 69.11 84.90 231 8988 0.0257 0.1605
MN20160318_Q02
I11
MCF 10A-H2B-mCherry Dasatinib
0.031667
 69.11 84.90 6392 8988 0.7112 0.9012
MN20160318_Q02
I11
MCF 10A-H2B-mCherry Dasatinib
0.031667
 70.81 84.90 717 9132 0.0785 0.3718
MN20160318_Q02
E06
MCF 10A-H2B-mCherry Dasatinib
0.031667
 70.81 84.90 5007 9132 0.5483 0.8296
MN20160318_Q02
E06
MCF 10A-H2B-mCherry Dasatinib
0.031667
 70.81 84.90 153 9132 0.0168 0.0912
MN20160318_Q02
I11
MCF 10A-H2B-mCherry Dasatinib
0.031667
 70.81 84.90 6409 9132 0.7018 0.8978
MN20160318_Q02
I11
MCF 10A-H2B-mCherry Dasatinib
0.031667
 72.52 84.90 234 9214 0.0254 0.1618
MN20160318_Q02
E06
MCF 10A-H2B-mCherry Dasatinib
0.031667
 72.52 84.90 4892 9214 0.5309 0.8212
MN20160318_Q02
E06
MCF 10A-H2B-mCherry Dasatinib
0.031667
 72.52 84.90 101 9214 0.0110 0.0260
MN20160318_Q02
I11
MCF 10A-H2B-mCherry Dasatinib
0.031667
 72.52 84.90 6363 9214 0.6906 0.8934
MN20160318_Q02
I11
MCF 10A-H2B-mCherry Dasatinib
0.031667
 74.22 84.90 59 9343 0.0063 -0.0522
MN20160318_Q02
E06
MCF 10A-H2B-mCherry Dasatinib
0.031667
 74.22 84.90 4780 9343 0.5116 0.8118
MN20160318_Q02
E06
MCF 10A-H2B-mCherry Dasatinib
0.031667
 74.22 84.90 66 9343 0.0071 -0.0364
MN20160318_Q02
I11
MCF 10A-H2B-mCherry Dasatinib
0.031667
 74.22 84.90 6405 9343 0.6855 0.8917
MN20160318_Q02
I11
MCF 10A-H2B-mCherry Dasatinib
0.031667
 75.93 84.90 20 8970 0.0022 -0.1935
MN20160318_Q02
E06
MCF 10A-H2B-mCherry Dasatinib
0.031667
 75.93 84.90 4641 8970 0.5174 0.8133
MN20160318_Q02
E06
MCF 10A-H2B-mCherry Dasatinib
0.031667
 75.93 84.90 22 8970 0.0025 -0.1820
MN20160318_Q02
I11